Filing Details
- Accession Number:
- 0001209191-23-047102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-23 17:56:22
- Reporting Period:
- 2023-08-21
- Accepted Time:
- 2023-08-23 17:56:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831828 | Vera Therapeutics Inc. | VERA | Pharmaceutical Preparations (2834) | 812744449 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1859453 | Marshall Fordyce | C/O Vera Therapeutics, Inc. 8000 Marina Boulevard, Suite 120 Brisbane CA 94005 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2023-08-21 | 5,210 | $16.66 | 243,361 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units pursuant to an election intended to satisfy the conditions of Rule 10b5-1(c) made by the Reporting Person on August 26, 2022.
- The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.893, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Includes shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022 for 1,085 shares, and on March 13, 2023 for 1,183 shares.
Billionaire Hedge Funds
